The Efficacy and Safety of Acupuncture for Depression-Related Insomnia: Protocol for a Systematic Review and Meta-Analysis
Hantong Hu,Zengtu Li,Yingying Cheng,Hong Gao
DOI: https://doi.org/10.2147/JPR.S370476
IF: 2.8319
2022-07-13
Journal of Pain Research
Abstract:Hantong Hu, 1, 2, &ast Zengtu Li, 3, &ast Yingying Cheng, 1, 2, &ast Hong Gao 1, 2 1 Department of Acupuncture and Moxibustion, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou City, People's Republic of China; 2 Department of Neurobiology and Acupuncture Research, the Third Clinical Medical College, Zhejiang Chinese Medical University, Key Laboratory of Acupuncture and Neurology of Zhejiang Province, Hangzhou City, People's Republic of China; 3 Department of Massage, the Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou City, People's Republic of China &astThese authors contributed equally to this work Correspondence: Hong Gao, Department of Acupuncture and Moxibustion, The Third Affiliated Hospital of Zhejiang Chinese Medical University, No. 219 Moganshan Road, Xihu District, Hangzhou City, People's Republic of China, Email Background: There is a bidirectional relationship between depression and insomnia. Depression-related insomnia is common and remains a challenging medical condition. Although acupuncture might be a potential treatment option and increasing randomized controlled trials (RCTs) have emerged, currently available evidence regarding the effect and safety of acupuncture on depression-related insomnia remains inconclusive. Thus, this protocol aims to systematically synthesize the evidence about the efficacy and safety of acupuncture for depression-related insomnia. Methods and Analysis: Eligible RCTs will be searched in nine representative databases and pooled in meta-analyses using RevMan 5.3. The methodological quality of included studies will be rated by Cochrane's risk of bias 2.0 tool. The quality of evidence will be appraised using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. Subgroup analysis, sensitivity analyses, and publication bias will also be conducted. Discussion: This protocol outlines the planned scope and methodology for an upcoming systematic review meta-analysis, which will critically synthesize the evidence about the efficacy and safety of acupuncture on depression-related insomnia. Findings will shed light on fulfilling evidence gaps and influence evidence-based treatment decisions for clinicians in the treatment of depression-related insomnia. Keywords: acupuncture, depression-related insomnia, systematic review, meta-analysis Insomnia is featured with reduced sleep quality or quantity, difficulty falling asleep, frequent nighttime awakenings, and/or early morning awakenings. It is widely accepted that there is a close relationship between depression and insomnia. Specially, abnormal changes in the normal sleep–wake cycle are frequently reported in patients with depression, and in many cases, sleep disturbance is the major complaint of depression. 1 Given that depression can significantly affect the normal sleep structure, persistent insomnia is one of the most prominent symptoms in depressive patients. 2 It is reported that approximately 60–80% of the depressive patients suffer from persistent insomnia. 3 What is worse, reduced sleep quality and quantity may persist even if depressive symptoms have been adequately relieved. In recent years, the bidirectional association between depression and insomnia has been further investigated. Insomnia can increase the risk of depression, which in turn raises the risk of developing and worsening insomnia. The emerging new perspective regards that insomnia is not only an epiphenomenon of depression but also a prodromal symptom with significant predictive value. 4 Therefore, it is now considered that persistent insomnia is an independent diagnostic entity that may precipitate the onset and development of depressive disorders. 4 Relieving insomnia improves clinical outcomes of depression. 5 In such situations, increasing attention has been paid to the sleep-specific treatment needs for patients with depression. Notably, depressive patients who suffer from clinically significant insomnia tend to present more severe symptoms and treatment difficulties, 6 making them a particularly challenging group to treat. 7 At present, the treatment of depression-related insomnia is mainly based on pharmacological treatment, complemented with cognitive behavioral therapy (CBT) and other treatments. 8–10 Although pharmacological treatment, represented by antidepressants and sedative-hypnotics, can improve the efficacy and prognosis in the treatment, the application of drugs is often limited by inevitable side effects, such as nausea, addiction, tol -Abstract Truncated-
clinical neurology